阿尔茨海默氏症Aβ对细胞外囊泡的特定结合
Christina Coughlan1, Jared Lindenberger2,3, Jeffrey G Jacot4
1University of Colorado Alzheimer's and Cognition Center (CUACC), Linda Crnic Institute for Down Syndrome (LCI), Department of Neurology, University of Colorado Anschutz Medical Campus, 13001 E. 17th Pl, Aurora, CO 80045, USA.
International journal of molecular sciences
|April 13, 2024
概括
细胞外囊泡 (EVs) 特别结合粉样β 42 和 40 . 这表明,EVs可能会从大脑中运输粉样蛋白,并可能作为阿尔茨海默病的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 的进展尚不清楚,而粉样β (Aβ) 的存在定义了AD连续性.
- 在AD进展过程中血Aβ42的降低表明大脑聚合增加,通过脑脊液 (CSF) 从大脑到血的运输减少.
- 细胞外囊泡 (EVs) 参与体液和细胞之间的生物分子的运输.
研究的目的:
- 为了研究粉样β (Aβ) 和细胞外囊泡 (EVs) 之间的特定相互作用.
- 为了确定Aβ-EV相互作用是否在阿尔茨海默病 (AD) 发病过程中起作用,或者可以作为特定于大脑的生物标志物.
主要方法:
- 异热定位热量计 (ITC) 用于分析Aβ42/Aβ40和EVs之间的结合动力学.
- 一夜间将Aβ和EV化,以评估结合的Aβ的结构变化.
主要成果:
- Aβ42和Aβ40表明了对EVs的序列特定,和和内热结合.
- 化导致纤维状Aβ与EVs结合的数量增加.
结论:
- 粉样β和细胞外囊泡之间存在一种特定的相互作用.
- EVs可能会促进粉样蛋白从大脑到血液的运输.
- 携带粉样蛋白的EV可能参与阿尔茨海默病的过程,并作为潜在的生物标志物.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Fusion of Secretory Vesicles with the Plasma Membrane
11.1K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
11.1K
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183
Overview of Secretory Vesicles
8.5K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.5K


